Appendix 2Public Hearings
Wednesday, 31 January 2024
Corinthian Room, Sydney Masonic Centre
66 Goulburn St
Sydney
Cancer Council Australia
Ms Megan Varlow, Director, Cancer Control Policy
Rare Cancers Australia
Ms Christine Cockburn, Chief Executive Officer
Head and Neck Cancer Australia
Ms Nadia Rosin, Chief Executive Officer
Ms Carolyn Smith, Board Director
Mr Matthew Magarey, Board Director
Neuroblastoma Australia
Ms Lucy Jones, Chief Executive Officer
Leukaemia Foundation
Mr Tim Murphy, General Manager, Blood Cancer Partnerships
Mrs Julia Sammut, Private capacity
Cancer Assistance Network
Mrs Emma Phillips, Executive Director
Ms Majella Gallagher, Advocacy and External Relations
Australian Cancer Atlas
Dr Kerrie Mengersen, Distinguished Professor, Centre for Data Science, Queensland University of Technology
Dr Peter Baade, Senior Manager, Descriptive Epidemiology, Cancer Council Queensland
Private Cancer Physicians of Australia
Associate Professor Christopher Steer, President
Professor Matthew Dun, Professor of Paediatric Haematology and Oncology Research, Founder and Director of RUN DIPG
Australian DIPG families
Mrs Beau Kemp
Mrs Hannah Pringle
Ms Angie Sari-Daher
Kate, Private capacity
Michelle, Private capacity
Children’s Cancer Institute
Dr Peter Wejbora, Director Research Development and Partnerships
Dr Emily Mould, Head of Business Development
Ms Anastasia Glushko, Stakeholder Engagement Manager
Sydney Children’s Hospitals Network
Dr Richard Mitchell, Director, Kids Cancer Centre, Sydney Childrens Hospital Randwick
Dr Luciano Dalla-Pozza, Senior Staff Specialist and Director, Cancer Centre for Children, The Childrens Hospital at Westmead
Associate Professor Antoinette Anazodo, Paediatric and Adolescent Oncologist, Sydney Childrens Hospital Randwick
Clinical Oncology Society of Australia
Dr David Chan, Chair, Neuroendocrine Tumours Group
The Daffodil Centre
Professor Karen Veronica Canfell, Director
The Daffodil Centre and the University of Sydney Cancer Research Network
Professor Stephen Clarke
University of Sydney Cancer Research Network
Professor Anna Defazio, Convenor
Associate Professor Kathy Tucker, Private capacity
IQVIA
Mr Andrew Sutton, Vice President and General Manger
Mr Quentin Bracquart, Head of Payer, Provider and Government Services and Principal, Strategic Insights and Analytics
Roche
Mr Ben Robinson, Head, Access and Innovation
Dr Richard Woodfield, Country Medical Director
AstraZeneca
Ms Penny George, Director of Corporate Affairs
Ms Rachael Anderson, Market Access Director
Thursday, 1 February 2024
Edinburgh Room, Stamford Plaza Melbourne
111 Little Collins St
Melbourne
NeuroEndocrine Cancer Australia
Ms Meredith Cummins, Chief Executive Officer
Professor Rodney Hicks, Honorary Board Member
Peter MacCallum Cancer Centre
Associate Professor Grace Kong, Medical Consultant, Nuclear Medicine Physician and Co-Chair, Neuroendocrine Tumour Unit
Mrs Kate Wakelin, Neuroendocrine Tumour Clinical Nurse Consultant
Associate Professor Benjamin Loveday, Surgical Oncologist
Mrs Susanne Manks, Patient
Lymphoma Australia
Ms Sharon Winton, Chief Executive Officer
Australasian Leukaemia and Lymphoma Group
Ms Delaine Smith, Chief Executive Officer
Rotary Outreach Myeloma Program
Mr Peter Allen OAM, Secretary
Mrs Patricia Marjorie O'Hara OAM, Committee Member
Australian Genomics
Mrs Tiffany Boughtwood, Managing Director
Dr Jane Tiller, Ethical, Legal and Social Adviser, Public Health Genomics, Monash University
Professor Paul Lacaze, Head of Public Health Genomics, School of Public Health and Preventative Medicine, Monash University
Emily, Private capacity
Jelena, Private capacity
Katherine, Private capacity
Kristina, Private capacity
Michael, Private capacity
Caitlin, Private capacity
Cancer Trials Australia
Dr Kurt Lackovic, Chief Executive Officer
Professor Clare Scott, Board Member
TrialHub
Ms Anne Woollett, Director
Dr Chloe Georgiou, Chair, Victorian Rare Cancer, Clinical Trial Alliance
Professor Clare Scott, Co-Chair, Victorian Rare Cancer, Clinical Trial Alliance
Victorian Cancer Biobank
Dr Wayne Ng, General Manager
Royal Australian College of General Practitioners
Professor Mark Morgan, Chair, Expert Committee for Quality Care
Society of Hospital Pharmacists of Australia
Mr Jerry Yik, Head, Policy and Advocacy
Mr Shaun O'Connor, Co-Chair, Oncology and Haematology Leadership Committee
Ovarian Cancer Australia
Associate Professor Anna Boltong, Chief Executive Officer
Mrs Bridget Bradhurst, Acting Chief of Support and Advocacy
Ms Claire MacDonald, Governance Manager
Pancare Foundation
Mr Doug Hawkins, Chief Executive Officer
Mr David Menzies, Head of PanSupport
Omico
Professor David Thomas, Chief Executive Officer
Bristol-Myers Squibb Australia
Mr Owen Smith, Managing Director
Ipsen
Mr Julien Dagher, General Manager Australia & New Zealand
Mr Simon Higgins, Director, Public Affairs and Market Access
Tuesday, 20 February 2024
Centurion 1, Crowne Plaza Hobart
110 Liverpool St
Hobart
Menzies Institute for Medical Research, University of Tasmania
Professor Joanne Dickinson, Lead, Cancer Genetics
Royal Hobart Hospital
Dr Thomas (Tom) Walwyn, Staff Specialist, Paediatric, Adolescent and Young Adult Oncology
Dr Anna Johnston, Director of Clinical Haematology
Dr Melanie (Mel) Wuttke, Head of Medical Oncology
Glen, Private capacity
Jacqui, Private capacity
Jenaya, Private capacity
Judi, Private capacity
Lesley, Private capacity
Peter, Private capacity
Robert, Private capacity
Friday, 1 March 2024
Committee Room 1S3, Parliament House
Parliament Dr
Canberra
ZERO Childhood Cancer Program
Associate Professor Vanessa Tyrrell, Director
Ms Anastasia Glushko, Stakeholder Engagement Manager, Children’s Cancer Institute
Professor Nick Gottardo, Head, Department of Paediatric Oncology and Haematology, Perth Children's Hospital; and Chair, Australian and New Zealand Children's Haematology and Oncology Group
Australian Teletrial Program
Ms Kaye Hewson, Director, Australian Teletrial Program, National Office, Queensland Health
Dr Julie White, Executive Director, Office of Research and Innovation
Dr Wei-Sen Lam, Medical Lead, Teletrials, WA Country Health Service
Canberra Health Services
Ms Clare Crawford, Senior Director, Revenue and Hospital Financial Services
Mrs Florence Young, Executive Branch Manager and Deputy Chief Financial Officer
National Rural Health Alliance
Ms Clare Fitzmaurice, Policy and Data Analytics Officer
Ms Margaret Deerain, Director of Policy and Strategy Development
Dr Ian Kamerman, Secretary, Rural Doctors Association NSW
Cancer Australia
Professor Dorothy Keefe, Chief Executive Officer
Ms Claire Howlett, Deputy Chief Executive Officer
Department of Health and Aged Care
Ms Adriana Platona, First Assistant Secretary, Technology Assessment and Access Division
Ms Renaye Lucchese, Assistant Secretary, Genomics and Health
Mrs Ariane Hermann, Acting First Assistant Secretary
Dr Masha Somi, Assistant Secretary, Health and Medical Research Office
Ms Natasha Ploenges, Chief Executive Officer, Health and Medical Research Office
National Health and Medical Research Council
Dr Nicholas Johnson, Executive Director, Research Partnerships Branch
Dr Julie Glover, Research Foundations Branch
Tuesday, 9 April 2024
Banqueting Room, Adelaide Town Hall
Adelaide
Cancer Council South Australia
Dr Peter Diamond, General Manager Support and Research
Mrs Amanda Robertson, Information and Support Manager
Mrs Miriam Cocking, Private capacity
Angel Flight Australia
Mr Howard Hobbs, Chair
Royal Adelaide Hospital
Professor Hamish Scott, Head of Department, Genetics and Molecular Pathology, SA Pathology
Dr Anna Brown, Head, Molecular Oncology, SA Pathology
The Hospital Research Foundation Group
Mr Paul Flynn, Group Chief Executive Officer
Associate Professor Gabby Cehic AM, Clinical Lead, South Australian Peptide Receptor Radionuclide Therapy Service, and Chair, South Australian Gastroenteropancreatic Neuroendocrine Tumours Multidisciplinary Team, South Australia Medical Imaging
Dr Sally Cox, Private capacity